Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer

Building on New Insights in Tumor Biology Discovered by Award-winning Cancer Researcher Thomas Gajewski, MD, PhD USD 22 Million Series A to Fund Pipeline of Antibodies Focused on Novel Immuno-oncology Targets Leverkusen, Germany and Boston, Mass., July 17, 2019 – Pyxis Oncology (“Pyxis”), a newly formed immuno-oncology company, launched today with a focus on developing a …

Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer Read More »